BioSpace News Archive

Biotech Beach

Palisade Bio (Nasdaq: PALI) to Participate in the 2022 Virtual Growth Conference Presented by Maxim Group and Hosted by M-Vest

Palisade Bio, Inc. announced that of Palisade Bio, will participate in the 2022 Virtual Growth Conference, presented by Maxim Group LLC and hosted by M-Vest, taking place on March 28–30, 2022.

March 24, 2022
·
2 min read
Business

RenovaCare Announces Management Changes

RenovaCare, Inc., a clinical-stage developer of patented technologies for isolating and spraying cells for the regeneration of skin and other organs and tissues, announced reductions in its management team to further streamline administrative expenses.

March 24, 2022
·
6 min read
Biotech Beach

Neurocrine Biosciences to Present Data from Movement Disorder Portfolio at the American Academy of Neurology 2022 In-Person and Virtual Annual Meeting

Neurocrine Biosciences, Inc. (Nasdaq: NBIX) today announced that it will present data from its movement disorders program and telemedicine research at the American Academy of Neurology (AAN) Annual Meeting being held in person April 2–7, 2022 in Seattle and virtually April 24–26.

March 24, 2022
·
13 min read
Biotech Beach

Simulations Plus Hosts the 2022 Model-Informed Drug Development (MIDD+) Scientific Conference

Simulations Plus, Inc. announced record-setting attendance and virtual content delivery for the 2022 MIDD+ Scientific Conference which was held February 16–17, 2022.

March 24, 2022
·
4 min read
Business

Can-Fite Reports 2021 Financial Results & Provides Clinical Update

Can-Fite BioPharma Ltd. today announced financial results for the year ended December 31, 2021.

March 24, 2022
·
13 min read
Biotech Bay

Tenaya Therapeutics to Participate in Upcoming Investor Conferences

Tenaya Therapeutics, Inc., a biotechnology company with a mission to discover, develop and deliver curative therapies that address the underlying causes of heart disease, announced participation in two upcoming investor conferences.

March 24, 2022
·
1 min read
Bio NC

Novan Announces Late-Breaking Abstract Accepted for Presentation at American Academy of Dermatology’s (AAD) 2022 Annual Meeting

Novan, Inc., announced that data from its pivotal Phase 3 study of berdazimer gel 10.3% for the treatment of molluscum contagiosum was selected for an oral presentation at a late-breaker session at the American Academy of Dermatology’s 2022 Annual Meeting.

March 24, 2022
·
4 min read
Neovasc Announces Consolidation and Extension of Convertible Debt

Neovasc Inc. announced that, pursuant to a Restated Securities Purchase Agreement with Strul Medical Group LLC, on a private placement basis, it has issued an amended and restated convertible note.

March 24, 2022
·
9 min read
Pharm Country

SK life science to Present Latest XCOPRI® (cenobamate tablets) CV Data at the American Academy of Neurology 2022 Annual Meeting

SK life science will share four posters and two oral presentations on its anti-seizure medication (ASM) cenobamate.

March 24, 2022
·
11 min read
Pharm Country

Gilgamesh Announces Clinical Candidates For Two Programs With First In Human Dosing to Begin in Late 2022

Gilgamesh Pharmaceuticals today announced the nomination of two lead clinical candidates for the treatment of debilitating neuropsychiatric disorders such as depression, anxiety, PTSD, and substance use disorders.

March 24, 2022
·
2 min read